Source: Nature Communications. Unidades: FM, FCF
Subjects: INFECÇÕES POR VÍRUS DE RNA, VACINAS VIRAIS, VIROLOGIA
ABNT
MAEHR, Tanja et al. A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study. Nature Communications, v. 16, p. 1-15 art. 8374, 2025Tradução . . Disponível em: https://dx.doi.org/10.1038/s41467-025-64004-x. Acesso em: 10 nov. 2025.APA
Maehr, T., Lopez, J., Drake, G., Ferreira, F. M., Fraser, R., Mckown, R., et al. (2025). A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study. Nature Communications, 16, 1-15 art. 8374. doi:10.1038/s41467-025-64004-xNLM
Maehr T, Lopez J, Drake G, Ferreira FM, Fraser R, Mckown R, Kailath R, Morris S, Chambers A, Graves LP, Walker SL, Dastjerdi A, Edwards KL, Nakaya HTI, Steinbach F. A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study [Internet]. Nature Communications. 2025 ; 16 1-15 art. 8374.[citado 2025 nov. 10 ] Available from: https://dx.doi.org/10.1038/s41467-025-64004-xVancouver
Maehr T, Lopez J, Drake G, Ferreira FM, Fraser R, Mckown R, Kailath R, Morris S, Chambers A, Graves LP, Walker SL, Dastjerdi A, Edwards KL, Nakaya HTI, Steinbach F. A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study [Internet]. Nature Communications. 2025 ; 16 1-15 art. 8374.[citado 2025 nov. 10 ] Available from: https://dx.doi.org/10.1038/s41467-025-64004-x
